Eliem Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Eliem Therapeutics by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $357k | 70k | 5.09 |
2024-06-30 | $122k | 17k | 7.11 |
2022-03-31 | $135k | 16k | 8.44 |
2021-12-31 | $181k | 17k | 10.51 |
2021-09-30 | $310k | 17k | 18.00 |